Insider trading

Period: 120 months Stock: EW Plan: Not on a plan × + Add filter Clear all
Views & alerts

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

488 decisions over 120 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

488 decisions over 120 months
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

488 decisions over 120 months
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

488 decisions over 120 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
488 decisions over 120 months Remove this filter
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
488 decisions over 120 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

488 decisions over 120 months
Stock
Insider
Type ?
Why it stands out
31 Aug 2026
Dahl Andrew M. SVP, Corporate Controller
Sold at will
$49.53K 544 at 91.06
3.5%
Not planned
28 Aug 2026
Bruls Annette CVP, EMEACLA
Sold at will
$237.91K 2,644 at 89.98
12.8%
Not planned
26 Aug 2026
Chopra Daveen CVP, TMTT, Surgical & IHFM
Sold at will 2×
$2.89M 31,800 at 91.02
41.8%
Not planned
26 Aug 2026
Markowitz Wayne CVP, JAPAC
Sold at will
$113.42K 1,240 at 91.47
5.8%
Not planned
30 Jul 2026
Markowitz Wayne CVP, JAPAC
Sold at will
$12.59K 146 at 86.03
0.7%
Not planned
28 Jul 2026
Markowitz Wayne CVP, JAPAC
Sold at will
$818.96K 9,628 at 85.06
30.8%
Not planned
27 Jul 2026
Zovighian Bernard J CEO · indirect
Sold at will
$245.13K 2,921 at 83.93
24.7%
Not planned
29 May 2026
Dahl Andrew M. SVP, Corporate Controller
Sold at will
$48.85K 568 at 86.08
3.6%
Not planned
27 May 2026
BOBO DONALD E JR CVP,Strategy/Corp Development · indirect
Sold at will
$2.00M 23,145 at 86.42
19.0%
Not planned
22 May 2026
Chopra Daveen CVP, TMTT & Surgical
Sold at will
$126.91K 1,500 at 84.60
3.3%
Not planned
15 May 2026
BOBO DONALD E JR CVP,Strategy/Corp Development
Sold at will
$818.11K 9,968 at 82.07
30.4%
Not planned
15 May 2026
BOBO DONALD E JR CVP,Strategy/Corp Development · indirect
Sold at will
$654.57K 8,000 at 81.82
20.5%
Not planned
11 May 2026
Markowitz Wayne CVP, JAPAC
Sold at will
$47.28K 593 at 79.73
2.7%
Not planned
25 Feb 2026
BOBO DONALD E JR CVP,Strategy/Corp Development
Sold at will
$2.01M 24,000 at 83.84
53.0%
Sold half or more
12 Feb 2026
Sold at will 2×
$1.72M 22,430 at 76.67
21.1%
Not planned
12 Dec 2025
BOBO DONALD E JR CVP,Strategy/Corp Development
Sold at will 2×
$953.75K 11,386 at 83.76
22.6%
Not planned
12 Dec 2025
Sold at will
$218.12K 2,615 at 83.41
7.8%
Not planned
11 Dec 2025
Chopra Daveen CVP, TMTT & Surgical
Sold at will
$168.75K 2,000 at 84.38
5.8%
Not planned
8 Dec 2025
Markowitz Wayne CVP, JAPAC
Sold at will
$50.14K 583 at 86.01
3.2%
Not planned
25 Aug 2025
Chopra Daveen CVP, TMTT
Sold at will
$204.87K 2,500 at 81.95
7.5%
Not planned
28 Jul 2025
Lippis Daniel J. CVP, JAPAC
Sold at will
$326.90K 4,114 at 79.46
15.8%
Not planned
22 May 2025
Chopra Daveen CVP, TMTT
Sold at will
$112.61K 1,500 at 75.08
4.3%
Not planned
7 May 2025
Markowitz Wayne GM & SVP, Surgical
Sold at will
$20.12K 268 at 75.08
2.8%
Not planned
14 Feb 2025
Sold at will
$438.58K 5,739 at 76.42
8.7%
Not planned
13 Feb 2025
Sold at will
$435.37K 5,739 at 75.86
16.0%
Not planned
6 Dec 2024
Chopra Daveen CVP, TMTT
Sold at will
$128.22K 1,750 at 73.27
6.0%
Not planned
6 Dec 2024
Markowitz Wayne GM & SVP, Surgical
Sold at will
$42.72K 583 at 73.27
5.8%
Not planned
20 Aug 2024
Chopra Daveen CVP, TMTT
Sold at will
$87.44K 1,250 at 69.95
4.1%
Not planned
6 May 2024
Zovighian Bernard J CEO · indirect
Bought
$49.75K 580 at 85.74
21.6%
First buy on file
23 Feb 2024
GALLAHUE KIERAN Director · indirect
Sold at will
$267.91K 3,058 at 87.61
4.4%
Not planned
21 Feb 2024
Chopra Daveen CVP, TMTT
Sold at will 2×
$711.27K 8,200 at 86.74
26.5%
Not planned
15 Feb 2024
Szyman Catherine M. CVP, Critical Care
Sold at will
$2.31M 27,000 at 85.62
43.7%
Not planned
13 Feb 2024
Szyman Catherine M. CVP, Critical Care
Sold at will
$1.73M 20,000 at 86.46
36.5%
Not planned
12 Feb 2024
SELLERS ROBERT W.A. SVP, Corporate Controller
Sold at will
$1.06M 12,210 at 87.00
48.3%
Not planned
8 Feb 2024
Sold at will
$609.99K 7,056 at 86.45
20.7%
Not planned
15 Dec 2023
Chopra Daveen CVP, TMTT
Sold at will
$547.72K 7,000 at 78.25
22.6%
Not planned
29 Aug 2023
Chopra Daveen CVP, TMTT
Sold at will
$115.04K 1,500 at 76.69
5.9%
Not planned
10 Aug 2023
Sold at will
$260.51K 3,303 at 78.87
10.9%
Not planned
5 May 2023
BOBO DONALD E JR CVP,Strategy/Corp Development
Sold at will
$499.40K 5,635 at 88.63
9.1%
Not planned
28 Apr 2023
SELLERS ROBERT W.A. SVP, Corporate Controller
Sold at will
$1.07M 12,270 at 87.20
51.1%
Sold half or more
15 Mar 2023
Chopra Daveen CVP, TMTT
Sold, plan not stated
$343.56K 4,435 at 77.47
19.0%
14 Mar 2023
MUSSALLEM MICHAEL A Chairman & CEO
Sold, plan not stated 2×
$1.54M 19,875 at 77.61
24.6%
8 Mar 2023
BOBO DONALD E JR CVP,Strategy/Corp Development
Sold, plan not stated
$517.56K 6,725 at 76.96
9.7%
8 Mar 2023
Lemercier Jean-Luc M CVP, EMEACLA and JAPAC
Sold, plan not stated 2×
$511.00K 6,640 at 76.96
3.8%
16 Feb 2023
Sold, plan not stated
$742.94K 9,671 at 76.82
26.0%
15 Feb 2023
Chopra Daveen CVP, TMTT
Sold, plan not stated
$304.04K 4,000 at 76.01
17.5%
14 Feb 2023
MUSSALLEM MICHAEL A Chairman & CEO
Sold, plan not stated 2×
$1.53M 19,875 at 77.00
11.2%
6 Feb 2023
BOBO DONALD E JR CVP,Strategy/Corp Development
Sold, plan not stated
$543.04K 6,725 at 80.75
9.7%
17 Jan 2023
Chopra Daveen CVP, TMTT
Sold, plan not stated
$312.00K 4,000 at 78.00
17.5%
13 Jan 2023
MUSSALLEM MICHAEL A Chairman & CEO
Sold, plan not stated
$1.55M 19,875 at 78.09
11.2%
Showing 1–50 of 488. Page 1 of 10 Older →